Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



SHARP PHILLIP A Create: Alert

All | News | Filings
Date FiledTypeDescription
05/24/2023 4 SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns: Granted 6,027 shares @ $0
Granted 12,054 options to buy @ $25.74, valued at $310.3k
05/19/2023 4 SHARP PHILLIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,454 options to buy @ $189.87, valued at $655.8k
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2021 4 SHARP PHILLIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 4,032 options to buy @ $171.95, valued at $693.3k
06/10/2021 4 SHARP PHILLIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 17,500 options to buy @ $6.3, valued at $110.3k
05/25/2021 4 SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns: Granted 3,374 shares @ $0
Granted 6,748 options to buy @ $45.28, valued at $305.5k
12/22/2020 4 SHARP PHILLIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Gifted 235,633 shares @ $0
Gifted 235,633 shares @ $0
11/30/2020 4 SHARP PHILLIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Sold 11,523 shares @ $124.3, valued at $1.4M
Sold 15,715 shares @ $125.05, valued at $2M
Sold 2,117 shares @ $126.16, valued at $267.1k
Sold 645 shares @ $127.44, valued at $82.2k
Exercised 30,000 options to buy @ $9.3, valued at $279k
07/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2020 4 SHARP PHILLIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 17,500 options to buy @ $9.17, valued at $160.5k
05/26/2020 4 SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns: Granted 28,888 options to buy @ $37.06, valued at $1.1M
02/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/18/2019 4 SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns: Converted 88,888 shares @ $0
Converted 44,444 shares @ $0
Converted 44,444 shares @ $0
Converted 44,444 shares @ $0
Converted 88,888 convertible preferred @ $0
Converted 44,444 convertible preferred @ $0
Converted 44,444 convertible preferred @ $0
Converted 44,444 convertible preferred @ $0
10/11/2019 4 SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns: Granted 22,222 options to buy @ $20, valued at $444.4k
07/02/2019 4 SHARP PHILIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 9,000 options to buy @ $72.01, valued at $648.1k
06/12/2019 4 SHARP PHILIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 11,000 options to buy @ $5.6, valued at $61.6k
04/17/2019 4 SHARP PHILIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Sold 11,800 shares @ $87.86, valued at $1M
Sold 2,200 shares @ $89.03, valued at $195.9k
Sold 400 shares @ $89.97, valued at $36k
Sold 600 shares @ $91.4, valued at $54.8k
Exercised 15,000 options to buy @ $22.09, valued at $331.4k
06/22/2018 4 SHARP PHILIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 9,000 options to buy @ $105.26, valued at $947.3k
06/15/2018 4 SHARP PHILIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 11,000 options to buy @ $12.95, valued at $142.5k
03/14/2018 4 SHARP PHILIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Sold 15,000 shares @ $149, valued at $2.2M
Exercised 15,000 options to buy @ $21.35, valued at $320.3k
03/13/2018 4 SHARP PHILIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Sold 15,000 shares @ $129, valued at $1.9M
Exercised 15,000 options to buy @ $27.28, valued at $409.2k
06/12/2017 4 SHARP PHILIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 11,000 options to buy @ $14.26, valued at $156.9k
06/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
09/19/2016 4 SHARP PHILIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
07/06/2016 4 SHARP PHILIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Converted 146,666 shares @ $0
Converted 40,000 shares @ $0
Converted 40,000 shares @ $0
Converted 40,000 shares @ $0
Converted 550,000 preferred shares @ $0
Converted 150,000 preferred shares @ $0
Converted 150,000 preferred shares @ $0
Converted 150,000 preferred shares @ $0
06/07/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy